Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

4.09
+0.02000.49%
Post-market: 4.310.2200+5.38%18:31 EDT
Volume:492.02K
Turnover:2.01M
Market Cap:458.08M
PE:-2.60
High:4.19
Open:4.15
Low:4.05
Close:4.07
52wk High:4.74
52wk Low:1.05
Shares:112.00M
Float Shares:92.24M
Volume Ratio:0.65
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5758
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-22.99%
PB:-2.30
PE(LYR):-2.52

Loading ...

ADC Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jun 20

RBC Adjusts Price Target on ADC Therapeutics Ltd to $5 From $8, Maintains Outperform, Speculative Risk Rating

MT Newswires Live
·
Jun 20

ADC Therapeutics SA to Present Updated ZYNLONTA® Trial Data at International Conference on Malignant Lymphoma

Reuters
·
Jun 16

ADC Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 13

ADC Therapeutics to Cut 30% of Workforce, Shutter UK Site

MT Newswires Live
·
Jun 12

Press Release: ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

Dow Jones
·
Jun 12

ADC Therapeutics Announces Promising LOTIS-7 Trial Results for ZYNLONTA® & Glofitamab Combo in r/r DLBCL Patients

Reuters
·
Jun 12

ADC Therapeutics SA Conducted Annual General Meeting

Reuters
·
Jun 06

ADC Therapeutics SA Announces New Inducement Plan with Stock Options for New Employees

Reuters
·
Jun 03

ADC Therapeutics SA Unveils Corporate Presentation Highlighting ZYNLONTA Expansion and Next-Gen ADC Developments

Reuters
·
May 22

ADC Therapeutics Price Target Maintained With a $8.00/Share by RBC Capital

Dow Jones
·
May 15

ADC Therapeutics SA to Participate in RBC Capital Markets Global Healthcare Conference

Reuters
·
May 15

ADC Therapeutics SA reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

ADC Therapeutics Reports Stable Q1 2025 Product Revenues at $17.4M, License Revenues Surge to $5.6M

Reuters
·
May 14

Press Release: ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Dow Jones
·
May 14

Pyxis Oncology Inc. to Participate in RBC Capital Markets Global Healthcare Conference

Reuters
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

ADC Therapeutics SA expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 12

ADC Therapeutics SA expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 02